The protective effects of resveratrol pretreatment in cyclophosphamide-induced rat ovarian injury: an vivo study

作者：Zhaoyan Nie, Lei Zhang, Wei Chen, Yanan Zhang, Wei Wang, Rui Hua, Tiantian Zhang, Zhao Chunfang, Miao Gong, Haifeng Wu · 发表于：Gynecological Endocrinology · 年份：2021 · DOI：10.1080/09513590.2021.1885643 · 被引用次数：21 · 研究领域：Reproductive Biology and Fertility、Sirtuins and Resveratrol in Medicine、Ovarian cancer diagnosis and treatment

Objectives To explore whether resveratrol (Res) pretreatment could exert a protective effect on cyclophosphamide (Cy) induced ovarian toxicity in a rat model.Methods Twenty-four female 7-week old Sprague-Dawley rats were randomly divided into four groups: Con, administered with vehicle solutions; Cy, treated with Cy; Res + Cy, treated with Cy + Res combined; Res, treated with Res. After 21 d of treatments, the rats were euthanized and blood samples were collected to evaluate the levels of anti-Müllerian hormone (AMH). The Ovaries were processed for immunohistochemical and western blotting.Results Cy-treat caused the decrease of body weights and ovarian weight. AMH was lower in Cy group, whereas AMH levels were similar among other groups. Histomorphology showed a large number of primordial follicles were activated in Cy groups, whereas the primordial follicles were inhibited in the Res and Res + Cy groups. The expressions of Sirt1, Foxo3a were up-regulated and p53, Caspase-3, and Bax were down-regulated in Res + Cy and Res groups (p < .05).Conclusions Res can prevent the primordial follicle activation and decrease apoptosis induced by Cy. Res may be an effective protection for ovarian function during chemotherapy, which means a new nonsurgical application for protection of ovarian reserve.